Recent Articles from GlobeNewswire

KELLOGG, Idaho and VANCOUVER, British Columbia, May 06, 2026 (GLOBE NEWSWIRE) -- Bunker Hill Mining Corp. (“Bunker Hill” or the “Company”) (TSX: BNKR | OTCQB: BHLL) is pleased to announce the appointment of Mark Child as an Independent Non-Executive Director to the Company’s board of directors (the “Board”), effective May 6, 2026.

NEW YORK, May 06, 2026 (GLOBE NEWSWIRE) -- StepStone Group Inc. (Nasdaq: STEP) today announced that the Company will release its results for the fourth quarter and fiscal year ended March 31, 2026, after the market closes on Wednesday, May 20, 2026.

DURHAM, N.C., May 06, 2026 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or the "Company"), a global leader in innovations for active healing, today reported financial results for the three months ended March 28, 2026.

NORTHFIELD, Ill., May 06, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline” or the “Company”) (Nasdaq: MDLN), the largest provider of medical-surgical (“med-surg”) products and supply chain solutions serving all points of care3, today reported its operating results for the three months ended March 28, 2026.

Agreement establishes framework for cooperation on market infrastructure development using Abaxx’s MarketOS™ technology

- The approval of Beyonttra in Brazil is based on positive results from the Phase 3 ATTRibute-CM study, in which acoramidis demonstrated the most rapid benefit seen in any Phase 3 study of ATTR-CM to date, including:

200µg Cohort Achieves 55% Complete Response at Day 57 Emerging as Registrational Grade Lead Regimen

Company Continues to Advance on Roadmap for Autonomous Retail Platform Adoption Across Key High-growth Enterprise Verticals

WALTHAM, Mass., May 06, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced that management is scheduled to present at the following investor conferences in May:

VANCOUVER, British Columbia, May 06, 2026 (GLOBE NEWSWIRE) -- Stillwater Critical Minerals Corp. (TSX.V: PGE; OTCQB: PGEZF; FSE: J0G) (the “Company”, or “Stillwater”) a mineral exploration and development company advancing its 100%-owned Stillwater West Ni-PGE-Cu-Co + Au project in the Stillwater mining district of Montana, USA, today announced that Michael Rowley, President and CEO will present live at the Precious Metals & Critical Minerals Virtual Investor Conference hosted by VirtualInvestorConferences.com, on May 7, 2026.

NorCal Habit Restaurant to Open Doors on May 13; Hold Pre-Opening VIP Events on May 9, 11-12

SAN FRANCISCO, May 06, 2026 (GLOBE NEWSWIRE) -- Immusoft of CA, a clinical-stage biotechnology company pioneering engineered B cell therapies, today announced that Scott McIvor, Chief Development Officer at Immusoft, will present recent clinical data in a poster presentation at the American Society of Cell and Gene Therapy (ASGCT) 29th Annual Meeting, taking place May 11-15, 2026, in Boston, MA.

SANTA CLARA, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- Applied Materials, Inc. today announced that members of its management team will participate in fireside chats at upcoming investor conferences.

TORONTO, May 06, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabis company, announced today that Spinach STIX®, its latest innovation in its popular line-up of Spinach® pre-rolls, is now available in more provinces across Canada. Spinach STIX® is the brand’s first cylindrical-style pre-roll, designed to meet surging consumer interest in this highly sought-after format in the pre-roll category1.

Technology Commercialization Leader Expected to Enhance QLE's Government Partnerships and Advanced Materials Strategy

SCOTTSDALE, Ariz., May 06, 2026 (GLOBE NEWSWIRE) -- ON Semiconductor Corporation (Nasdaq: ON) (“onsemi”) announced today that it intends to offer, subject to market and other conditions, $1.3 billion aggregate principal amount of Convertible Senior Notes due 2031 (the “notes”) in a private offering. The notes will be offered only to persons reasonably believed to be qualified institutional buyers in accordance with Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). onsemi also expects to grant to the initial purchasers of the notes an option to purchase, within a 13-day period beginning on, and including, the date on which the notes are first issued, up to an additional $200.0 million aggregate principal amount of the notes.

Global specialty chemicals leader Nouryon has introduced Perkadox® PM-60ST-GR, a new organic peroxide technology for recycled polypropylene — one of the world's most widely used plastics — that is designed to restore performance in degraded, recycled plastic material. The first commercially available organic peroxide solution of its kind, this solution enables plastic recyclers, compounders and processors to use more recycled material in packaging, automotive and consumer goods applications that have traditionally required virgin polypropylene.

WASHINGTON, May 06, 2026 (GLOBE NEWSWIRE) -- The Transportation Institute (TI), representing U.S.-flag American shipping companies, today announced the appointment of Sara Fuentes as President of the organization. Fuentes previously served as the organization’s Vice President for Government Affairs and will lead TI’s continued work to advance a strong U.S.-flag merchant marine and a resilient American maritime workforce.

CALGARY, Alberta, May 06, 2026 (GLOBE NEWSWIRE) --

NEW YORK, May 06, 2026 (GLOBE NEWSWIRE) -- Marex Group plc (‘Marex’ or the ‘Group’; Nasdaq: MRX) a diversified global financial services platform, providing market access, infrastructure services and essential liquidity, to clients across global markets, today reported financial results for the first quarter ('Q1 2026').

NEW YORK, May 06, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, "Strata" or the "Company"), today announced financial results for the first quarter ended March 31, 2026. Financial results in this release, including all comparisons to prior year periods, reflect continuing operations only. The results of the divested Passenger business have been reclassified as discontinued operations in all periods.

New global survey reveals gap between employee feedback and action as Workvivo introduces Seer as a standalone solution, with industry veteran Justin Black at the helm

NEW YORK, May 06, 2026 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today reported financial results for the first quarter of 2026 and raised full year 2026 guidance for Portfolio Receipts.

EATONTOWN, N.J., May 06, 2026 (GLOBE NEWSWIRE) -- Climb, an international specialty technology distributor and wholly owned subsidiary of Climb Global Solutions, Inc. (NASDAQ: CLMB) today announced a new North American distribution partnership with Dashlane, a leader in credential security. Through this partnership, Climb will expand access to Dashlane’s intelligent credential security platform, Omnix, for U.S. and Canadian partners, enabling them to address one of the most critical and persistent attack vectors facing modern organizations—stolen and compromised credentials.

Revenue growth of 10% with 4.5% organic growth and 15% AMS/DRS organic growth Cash flows provided by operating activities increased $89M and free cash flow was up $66MNCR Atleos acquisition remains on track to close by the end of the first quarter of 2027

NEW YORK, May 06, 2026 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Yangarra Resources Ltd. (TSX: YGR; OTCQX: YGRAF), a Canadian junior oil and gas company, has qualified to trade on the OTCQX® Best Market. Yangarra Resources Ltd. upgraded to OTCQX from the Pink Limited™ Market.

Strong Experiential Services performance and improved Retailer Services profitability drove Adjusted EBITDA growth

Immunocore reports first quarter financial results and provides a business update

DALLAS, May 06, 2026 (GLOBE NEWSWIRE) -- Hyperion DeFi, Inc. (NASDAQ: HYPD) (“Hyperion DeFi” or the “Company”), the first U.S. publicly listed DeFi company building on Hyperliquid, today announced the pricing of a public offering of 2,777,778 shares of its common stock. The shares of common stock are being sold to the public at a price of $3.60 per share. All of the shares of common stock to be sold in the public offering are to be sold by Hyperion DeFi. The gross proceeds to Hyperion DeFi from the offering, before deducting the underwriting discounts and commissions and other offering expenses, are expected to be approximately $10.0 million. In addition, Hyperion DeFi has granted the sole underwriter a 30-day option to purchase up to an additional 416,666 shares of its common stock at the public offering price per share, less underwriting discounts and commissions. The offering is expected to close on May 7, 2026, subject to the satisfaction of customary closing conditions.

SAN JOSE, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- Energous Corporation d/b/a Energous Wireless Power Solutions (Nasdaq: WATT), a leader in over-the-air wireless power networks, today announced that it will participate in a fireside chat at Planet MicroCap Las Vegas 2026 Powered by MicroCapClub on Wednesday, June 17, 2026, at 12:30 PM (Pacific Time) at the Bellagio Resort & Hotel in Las Vegas, Nevada. Mallorie Burak, Chief Executive Officer and Chief Financial Officer, and Giampaolo Marino, Chief Strategy and Growth Officer, will participate in the fireside chat, hosted by Jon Hickman, Managing Director of Equity Research at Ladenburg Thalmann.

Early data on patients treated in Cohort C of the ALLOHA™ Phase 1 heme trial expected in the second quarter of 2026

BRISBANE, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST) (“Tempest”) today presents its most recent clinical data from its lead dual-targeting chimeric antigen receptor T-cell (“CAR-T”) therapy product candidate, TPST-2003, at the International Society for Cell & Gene Therapy (“ISCT”) Scientific Annual Meeting in Dublin, Ireland. Updates include the latest data from the ongoing REDEEM-1 Phase 1/2a trial evaluating TPST-2003, as well as progress in Tempest’s other dual-targeting CAR-T pipeline programs.

SHANGHAI, China, May 06, 2026 (GLOBE NEWSWIRE) -- GDS Holdings Limited (“GDS Holdings”, “GDS” or the “Company”) (NASDAQ: GDS; HKEX: 9698), a leading developer and operator of high-performance data centers in China, today announced that it will report its first quarter 2026 unaudited financial results after the close of the Hong Kong market and before the open of the U.S. market on May 20, 2026.

SINGAPORE, May 06, 2026 (GLOBE NEWSWIRE) -- Intchains Group Limited (Nasdaq: ICG) (“we,” or the “Company”), an integrated infrastructure provider of efficient altcoin mining and staking, today provided an update on the Company’s financial reporting structure, transitioning from quarterly to semi-annual reporting beginning in fiscal year 2026.

WARREN, N.J., May 06, 2026 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, today announced that it will report results for the first quarter ended March 31, 2026 and provide an update on recent developments in its business after market close on Wednesday, May 13, 2026.

~ Raises Fiscal 2026 Revenue Guidance and Introduces Fiscal 2026 Earnings Guidance ~

HOUSTON, May 06, 2026 (GLOBE NEWSWIRE) -- Natural Resource Partners L.P. (NYSE:NRP) today reported first quarter 2026 results as follows:

NEW YORK, May 06, 2026 (GLOBE NEWSWIRE) -- Apollo Global Management, Inc. (NYSE: APO) (together with its consolidated subsidiaries, “Apollo”) today reported results for the first quarter ended March 31, 2026.

DANBURY, Conn. and WESTLAKE VILLAGE, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products, today announced that it has been developing a dry powder inhalation (DPI) formulation of ralinepag, known as ralinepag DPI (MNKD-1501), for United Therapeutics Corporation (Nasdaq: UTHR), under the companies’ expanded license and collaboration agreement announcement from August 2025.

SALT LAKE CITY, May 06, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives, today reported business updates highlighting strong continued pipeline execution, clinical progress and platform advancement, as well as financial results for its first quarter ended March 31, 2026.

LAS VEGAS, May 06, 2026 (GLOBE NEWSWIRE) -- Planet 13 Holdings Inc. (CSE: PLTH) (OTCQX: PLNH) (“Planet 13” or the “Company”), a leading vertically-integrated multi-state cannabis company, announced today that it plans to release its financial results for the first quarter ended March 31, 2026, on May 13, 2026, aftermarket.

New AI agent answers technical product questions with unparalleled accuracy, helping retailers convert shoppers into buyers

NEW YORK, May 06, 2026 (GLOBE NEWSWIRE) -- Taboola (Nasdaq: TBLA), a global leader in delivering performance at scale for advertisers, today announced its results for the first quarter ended March 31, 2026.

Diamond Drilling at the Boin Gold Deposit Intersects Gold Mineralization in the Fresh Mineralization, Below the Limits of the Pits that Constrain the Mineral Resource Estimate

Strong Utility Products Performance

Earnings Call Scheduled for 8:30 a.m. U.S. Eastern Time on Wednesday, May 13, 2026

This news release constitutes a "Designated News Release" incorporated by reference in the prospectus supplement dated December 9, 2024 to Fortis' short form base shelf prospectus dated December 9, 2024.

Breach rates rise 18 percent annually despite increased security investment, exposing a widening gap as AI accelerates attacks beyond defenders’ visibility

CALGARY, Alberta, May 06, 2026 (GLOBE NEWSWIRE) -- Cenovus Energy Inc. (TSX: CVE) (NYSE: CVE) today announced its first-quarter 2026 financial and operating results. In the quarter, the company generated approximately $3.4 billion of adjusted funds flow and $2.2 billion of free funds flow. Operating results in the quarter included Upstream production of 972,100 barrels of oil equivalent per day (BOE/d)1 and Downstream crude throughput of 458,500 barrels per day (bbls/d), representing an overall crude unit utilization rate of 97%.

New Linux Foundation initiative convenes registry leaders to develop shared approaches to funding, governance, and long-term ecosystem resilience.

“Being able to share that reality with policymakers and other advocates and to say, ‘this kind of support should be a right and not a privilege,’ was incredibly powerful.” Supportive Cancer Care Treats the Whole Person, Not Just the Disease, Providing Emotional, Physical, and Logistical Support for People with Cancer and Their Caregivers

NEW YORK, May 06, 2026 (GLOBE NEWSWIRE) -- Pony AI Inc. (“Pony.ai” or the “Company”) (NASDAQ: PONY; HKEX: 2026), a global leader in achieving large-scale mass production and commercialization of autonomous driving technology, today announced that it will report its unaudited financial results for the first quarter 2026 before the U.S. market opens on Tuesday, May 26, 2026.

CERRITOS, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- GEN Restaurant Group, Inc. (“GEN” or the “Company”) (Nasdaq: GENK), owner of GEN Korean BBQ, a leading Korean BBQ brand, today announced a major expansion of its product offerings across premier Southern California destinations, including Downtown Disney and Knott’s Berry Farm.

Intelligent Virtual Agent brings trusted knowledge to every customer conversation

MUMBAI, India, May 06, 2026 (GLOBE NEWSWIRE) -- Lumina Datamatics, a strategic partner to global publishers and eCommerce retailers, has won the IMC RBNQA – Performance Excellence Trophy 2025 in the Service category. The award was presented at a prestigious ceremony held at the IMC Chamber of Commerce and Industry in Mumbai on 30th April 2026.

Embedded AI knowledge, case summarization, and KCS workflows support where agents already work, so teams resolve cases faster

New Agentic Studio capability reduces handle time, improves first contact resolution, and lowers service costs for complex customer requests

Enterprises now have a systematic way to test, monitor, and improve AI answer quality before issues reach customers

Unikie introduces UnikieMind, an agentic AI-platform for discovery and AI-driven software development to boost AI transformation within their clients and in the whole industry.

Wolters Kluwer First-Quarter 2026 Trading Update

LONDON and PHILADELPHIA, May 06, 2026 (GLOBE NEWSWIRE) -- Avacta Therapeutics (AIM: AVCT, "the Company", "Avacta"), a clinical stage biopharmaceutical company developing pre|CISION®, a tumor-activated oncology delivery platform, will today present two new developments at its Science Day 2026 event.

New tool helps small and mid-sized businesses handle data subject requests without dedicated privacy staff

The Admissions Reality Check: How Keith Berman is Replacing Reddit Rumors with Real Strategy

Press release06 May 2026 - N° 8

WISeKey Issues CEO Letter to Shareholders

May 6, 2026Q1 2026 Group performance

Equinor (OSE: EQNR, NYSE: EQNR) will, after the annual general meeting on 12 May 2026, commence the second tranche of up to USD 375 million of the share buy-back programme for 2026, as announced in connection with the company’s first quarter results on 6 May 2026.

Key information relating to the cash dividend to be paid by Equinor (OSE: EQNR, NYSE: EQNR) for first quarter 2026.

Equinor (OSE:EQNR, NYSE:EQNR) delivered an adjusted operating income* of USD 9.77 billion and USD 2.86 billion after tax* in the first quarter of 2026. Equinor reported a net operating income of USD 8.78 billion and a net income of USD 3.10 billion. Adjusted net income* was USD 3.70 billion, leading to adjusted earnings per share* of USD 1.48.

The trio unite in new campaign, It’s What You Bring, blending music, fashion, and football in a nod to the community behind the game

WAYNE, Pa., May 05, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (NASDAQ: AVTX) (“Avalo”), a clinical-stage biotechnology company fully dedicated to developing IL-1β based treatments for immune-mediated inflammatory diseases, today announced the pricing of its underwritten public offering of 19,730,000 shares of common stock and, in lieu of common stock to certain investors, pre-funded warrants to purchase 1,400,000 shares of common stock. The shares of common stock are being sold at a public offering price of $17.75 per share and the pre-funded warrants are being sold at a public offering price of $17.749 per pre-funded warrant, which represents the per share public offering price of each share of common stock, less the $0.001 per share exercise price for each pre-funded warrant. In addition, Avalo has granted the underwriters a 30-day option to purchase up to an additional 3,169,500 shares of its common stock on the same terms and conditions. The gross proceeds to Avalo from the offering are expected to be approximately $375 million, before deducting underwriting discounts and commissions and offering expenses payable by Avalo and assuming no exercise of the underwriters’ option to purchase additional shares. All of the securities being sold in the offering are being offered by Avalo. The offering is expected to close on May 7, 2026, subject to the satisfaction of customary closing conditions.

Klamath River Restoration Wins Top National Engineering Award